未登录
分享
收藏Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor TherapyFinerenone主要用于有或没有钠-葡萄糖Cotransporter-2抑制剂治疗的晚期CKD和2型糖尿病
Rossing, Peter; Filippatos, Gerasimos; Agarwal, Rajiv; Anker, Stefan D.; Pitt, Bertram; Ruilope, Luis M.; Chan, Juliana C. N.; Kooy, Adriaan; McCafferty, Kieran; Schernthaner, Guntram; Wanner, Christoph; Joseph, Amer; Scheerer, Markus F.; Scott, Charlie; Bakris, George L.
分享
收藏Finerenone in Patients with CKD and T2D by SGLT-2i Treatment: An Analysis of the FIDELIODKD Study
Rossing, Peter; Agarwal, Rajiv; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M.; Chan, Juliana; Kooy, Adriaan; McCafferty, Kieran; Schernthaner, Guntram; Wanne, Christoph
分享
收藏
分享
收藏
分享
收藏Finerenone in Patients with CKD and T2D by SGLT2i Treatment: An Analysis of the FIDELIO-DKD Study
Rossing, Peter; Agarwal, Rajiv; Anker, Stefan; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M.; Chan, Juliana C.; Kooy, Adriaan; Mccafferty, Kieran; Schernthaner, Guntram; Wanner, Christoph; Joseph, Amer; Scheerer, Markus F.; Scott, Charlie; Bakris, George
分享
收藏Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
Schernthaner, Guntram; Shehadeh, Naim; Ametov, Alexander S.; Bazarova, Anna V.; Ebrahimi, Fahim; Fasching, Peter; Janez, Andrej; Kempler, Peter; Konrade, Ilze; Lalic, Nebojsa M.; Mankovsky, Boris; Martinka, Emil; Rahelic, Dario; Serafinceanu, Cristian; Skrha, Jan; Tankova, Tsvetalina; Visockiene, Zydrune
分享
收藏Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes
Bethel, M. Angelyn; Stevens, Susanna R.; Buse, John B.; Choi, Jasmine; Gustavson, Stephanie M.; Iqbal, Nayyar; Lokhnygina, Yuliya; Mentz, Robert J.; Patel, Rishi A.; Ohman, Peter; Schernthaner, Guntram; Lecube, Albert; Hernandez, Adrian F.; Holman, Rury R.
分享
收藏
分享
收藏
分享
收藏Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs
Schernthaner, Guntram; Karasik, Avraham; Abraitiene, Agne; Ametov, Alexander S.; Gaal, Zsolt; Gumprecht, Janusz; Janez, Andrej; Kaser, Susanne; Lalic, Katarina; Mankovsky, Boris N.; Moshkovich, Evgeny; Past, Marju; Prazny, Martin; Radulian, Gabriela; Duvnjak, Lea Smircic; Tkac, Ivan; Trusinskis, Karlis
分享
收藏CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle
Schernthaner, Guntram; Wanner, Christoph; Jurisic-Erzen, Dubravka; Guja, Cristian; Gumprecht, Janusz; Jarek-Martynowa, Iwona R.; Karasik, Avraham; Lalic, Nebojsa; Mankovsky, Boris N.; Prazny, Martin; Tankova, Tsvetalina; Tsur, Anat; Wascher, Thomas C.; Wittmann, Istvan
分享
收藏
分享
收藏Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?
Schernthaner, Guntram; Lotan, Chaim; Baltadzhieva-Trendafilova, Elina; Ceponis, Jonas; Clodi, Martin; Ducena, Kristine; Goncalvesova, Eva; Guja, Cristian; Honka, Marek; Janez, Andrej; Lalic, Nebojsa; Lehmann, Roger; Nyolczas, Noemi; Pauklin, Priit; Rynkiewicz, Andrzej; Sergienko, Igor; Duvnjak, Lea Smircic
分享
收藏
分享
收藏Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)
Schernthaner, Guntram; Lehmann, Roger; Prazny, Martin; Czupryniak, Leszek; Ducena, Kristine; Fasching, Peter; Janez, Andrej; Karasik, Avraham; Kempler, Peter; Martinka, Emil; Shestakova, Marina V.; Duvnjak, Lea Smircic; Tankova, Tsvetalina
分享
收藏Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial
Groop, Per-Henrik; Cooper, Mark E.; Perkovic, Vlado; Hocher, Berthold; Kanasaki, Keizo; Haneda, Masakazu; Schernthaner, Guntram; Sharma, Kumar; Stanton, Robert C.; Toto, Robert; Cescutti, Jessica; Gordat, Maud; Meinicke, Thomas; Koitka-Weber, Audrey; Thiemann, Sandra; von Eynatten, Maximilian
分享
收藏
分享
收藏
分享
收藏
分享
收藏